Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion type Assertion NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_head.
- NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion description "[In gene expression profiling, the antiapoptotic protein survivin (BIRC5) demonstrated a striking increase in ATL, and its expression was increased in patient ATL cells resistant to the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_provenance.
- NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion evidence source_evidence_literature NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_provenance.
- NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion SIO_000772 23321252 NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_provenance.
- NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion wasDerivedFrom befree-20140225 NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_provenance.
- NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_assertion wasGeneratedBy ECO_0000203 NP722544.RA8rB9XTSIeR-ESdD4xi7lYMk-15oqsAeMFyQald1XUXU130_provenance.